ePrivacy and GPDR Cookie Consent by TermsFeed Generator

Search












The lists contain medicinal products or product categories subject to prescription which shall not bear the safety features (White list) and medicinal products or product categories not subject to prescription which shall bear the safety features (Black list)
Number of records: 6701
Name of the medicinal product Supplement
SÚKL code Registration Number SPC ? PIL ? ATC group MA status ?
GAVISCON 250MG/133,5MG/80MG TBL MND 6
0241364 09/ 574/10-C gaviscon.pdf gaviscon.pdf A02BX R
GAVISCON DUO EFEKT 500MG/213MG/325MG POR SUS SCC 4
0242354 09/ 351/13-C gaviscondu.pdf gaviscondu.pdf A02BX R
GAVISCON DUO EFEKT 500MG/213MG/325MG POR SUS SCC 12
0242355 09/ 351/13-C gaviscondu.pdf gaviscondu.pdf A02BX R
GAVISCON DUO EFEKT 500MG/213MG/325MG POR SUS SCC 24
0242356 09/ 351/13-C gaviscondu.pdf gaviscondu.pdf A02BX R
GAVISCON DUO EFEKT 500MG/213MG/325MG POR SUS 1X600ML VI
0258189 09/1052/10-C gaviscondu.pdf gaviscondu.pdf A02BX R
GAVISCON DUO EFEKT 500MG/213MG/325MG POR SUS SCC 48
0246327 09/ 351/13-C gaviscondu.pdf gaviscondu.pdf A02BX R
GAVISCON DUO EFEKT 500MG/213MG/325MG POR SUS SCC 48(2X24)
0246328 09/ 351/13-C gaviscondu.pdf gaviscondu.pdf A02BX R
GAVISCON DUO EFEKT 500MG/213MG/325MG POR SUS 1X150ML III
0247443 09/1052/10-C gaviscondu.pdf gaviscondu.pdf A02BX R
GAVISCON DUO EFEKT 500MG/213MG/325MG POR SUS 1X200ML III
0247444 09/1052/10-C gaviscondu.pdf gaviscondu.pdf A02BX R
GAVISCON DUO EFEKT 500MG/213MG/325MG POR SUS 1X300ML III
0247445 09/1052/10-C gaviscondu.pdf gaviscondu.pdf A02BX R
GAVISCON DUO EFEKT 500MG/213MG/325MG POR SUS 1X600ML III
0247446 09/1052/10-C gaviscondu.pdf gaviscondu.pdf A02BX R
GAVISCON DUO EFEKT 500MG/213MG/325MG POR SUS 1X150ML IV
0258178 09/1052/10-C gaviscondu.pdf gaviscondu.pdf A02BX R
GAVISCON DUO EFEKT 500MG/213MG/325MG POR SUS 1X200ML IV
0258179 09/1052/10-C gaviscondu.pdf gaviscondu.pdf A02BX R
GAVISCON DUO EFEKT 500MG/213MG/325MG POR SUS 1X300ML IV
0258180 09/1052/10-C gaviscondu.pdf gaviscondu.pdf A02BX R
GAVISCON DUO EFEKT 500MG/213MG/325MG POR SUS 1X600ML IV
0258181 09/1052/10-C gaviscondu.pdf gaviscondu.pdf A02BX R
GAVISCON DUO EFEKT 500MG/213MG/325MG POR SUS 1X150ML V
0258182 09/1052/10-C gaviscondu.pdf gaviscondu.pdf A02BX R
GAVISCON DUO EFEKT 500MG/213MG/325MG POR SUS 1X200ML V
0258183 09/1052/10-C gaviscondu.pdf gaviscondu.pdf A02BX R
GAVISCON DUO EFEKT 500MG/213MG/325MG POR SUS 1X300ML V
0258184 09/1052/10-C gaviscondu.pdf gaviscondu.pdf A02BX R
GAVISCON DUO EFEKT 500MG/213MG/325MG POR SUS 1X600ML V
0258185 09/1052/10-C gaviscondu.pdf gaviscondu.pdf A02BX R
GAVISCON DUO EFEKT 500MG/213MG/325MG POR SUS 1X150ML VI
0258186 09/1052/10-C gaviscondu.pdf gaviscondu.pdf A02BX R

‹‹ ‹ 20 30 40 50 60 70 71 72 73 74 75 76 77 78 79 80 90 100 110 120 130 200 300 › ››

Medicinal products reimbursed from health insurance are blue-tinged and marked with sign.

Medicinal products on the Czech market in line with periodical report from wholesalers in last 3 months (with monthly distance) are sign and are typed in bold

Last update of registration information: 17. May 2022 at 01:08
Last update of price and payment data: 30. April 2022 at 01:09